 SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the third quarter 2021 after market close on Thursday, October 28, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 